Synthesis of novel ursolic acid heterocyclic derivatives with improved abilities of antiproliferation and induction of p53, p21waf1 and NOXA in pancreatic cancer cells

被引：58
作者：
Leal, Ana S. [1 ,2 ,3 ]
Wang, Rui [3 ]
Salvador, Jorge A. R. [1 ,2 ]
Jing, Yongkui [3 ]
机构：
[1] Univ Coimbra, Quim Farmaceut Lab, Fac Farm, P-3000548 Coimbra, Portugal
[2] Univ Coimbra, CNC Ctr Neurociencias & Biol Celular, P-3000517 Coimbra, Portugal
[3] Mt Sinai Sch Med, Tisch Canc Inst, Div Hematol Oncol, New York, NY 10029 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2012年 / 20卷 / 19期
关键词：
Ursolic acid; Heterocyclic derivatives; Antiproliferative; p53; NOXA; OLEANOLIC ACID; INHIBITION; APOPTOSIS; PROLIFERATION; ACTIVATION; PATHWAY; GROWTH;
D O I：
10.1016/j.bmc.2012.08.010
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of new heterocyclic derivatives of ursolic acid 1 were synthesized and evaluated for their anti-proliferative activity against AsPC-1 pancreatic cancer cells. Compounds 24-32, with an alpha,beta unsaturated ketone in conjugation with an heterocyclic ring in ring A have improved antiproliferative activities. Compound 32 is the most active compound with an IC50 of 1.9 mu M which is sevenfold more active than ursolic acid 1. Compound 32 arrests cell cycle in G1 phase and induces apoptosis in AsPC-1 cells with upregulation of p53, p21(waf1) and NOXA protein levels. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5774 / 5786
页数：13
相关论文
共 50 条
  • [1] Semisynthetic Ursolic Acid Fluorolactone Derivatives Inhibit Growth with Induction of p21waf1 and Induce Apoptosis with Upregulation of NOXA and Downregulation of c-FLIP in Cancer Cells
    Leal, Ana S.
    Wang, Rui
    Salvador, Jorge A. R.
    Jing, Yongkui
    CHEMMEDCHEM, 2012, 7 (09) : 1635 - 1646
  • [2] Influence of p53 and p21WAF1 expression on sensitivity of cancer cells to cladribine
    Galmarini, CM
    Voorzanger, N
    Falette, N
    Jordheim, L
    Cros, E
    Puisieux, A
    Dumontet, C
    BIOCHEMICAL PHARMACOLOGY, 2003, 65 (01) : 121 - 129
  • [3] p53 and p21WAF1 expression in lymphocytic thyroiditis and thyroid tumors
    Okayasu, I
    Osakabe, T
    Onozawa, M
    Mikami, T
    Fujiwara, M
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 88 (02): : 183 - 191
  • [4] p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis
    Park, YN
    Chae, KJ
    Kwon, KW
    Oh, BK
    Lee, KS
    Lee, WJ
    Park, C
    HEPATO-GASTROENTEROLOGY, 2003, 50 (53) : 1292 - 1296
  • [5] p21B, a variant of p21Waf1/Cip1, is induced by the p53 family
    Nozell, S
    Chen, XB
    ONCOGENE, 2002, 21 (08) : 1285 - 1294
  • [6] p21B, a variant of p21Waf1/Cip1, is induced by the p53 family
    Susan Nozell
    Xinbin Chen
    Oncogene, 2002, 21 : 1285 - 1294
  • [7] Immunohistochemical study of p21WAF1 and p53 proteins in prostatic cancer and their prognostic significance
    Matsushima, H
    Sasaki, T
    Goto, T
    Hosaka, Y
    Homma, Y
    Kitamura, T
    Kawabe, K
    Sakamoto, A
    Murakami, T
    Machinami, R
    HUMAN PATHOLOGY, 1998, 29 (08) : 778 - 783
  • [8] Role of p53 in aziridinylbenzoquinone-induced p21waf1 expression
    Wu, RC
    Hohenstein, A
    Park, JM
    Qiu, XB
    Mueller, S
    Cadenas, E
    Schönthal, AH
    ONCOGENE, 1998, 17 (03) : 357 - 365
  • [9] Role of p53 in aziridinylbenzoquinone-induced p21waf1 expression
    Ray-Chang Wu
    Axel Hohenstein
    Ji Min Park
    Xiaobo Qiu
    Sebastian Mueller
    Enrique Cadenas
    Axel H Schönthal
    Oncogene, 1998, 17 : 357 - 365
  • [10] Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression
    Kralj, M
    Husnjak, K
    Körbler, T
    Pavelic, J
    CANCER GENE THERAPY, 2003, 10 (06) : 457 - 467
12345